Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BeOne Medicines - Operating Income 2014-2025 | ONC

BeOne Medicines - annual/quarterly operating income history and growth rate from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • BeOne Medicines - operating income for the quarter ending March 31, 2025 was $0.011B, a 104.25% decline year-over-year.
  • BeOne Medicines - operating income for the twelve months ending March 31, 2025 was $-0.296B, a 73.06% decline year-over-year.
  • BeOne Medicines - annual operating income for 2024 was $-0.568B, a 52.95% decline from 2023.
  • BeOne Medicines - annual operating income for 2023 was $-1.208B, a 32.52% decline from 2022.
  • BeOne Medicines - annual operating income for 2022 was $-1.79B, a 24.39% increase from 2021.
  
BeOne Medicines - Annual Operating Income
(Millions of US $)
2024 $-568
2023 $-1,208
2022 $-1,790
2021 $-1,439
2020 $-1,658
2019 $-960
2018 $-706
2017 $-98
2016 $-117
2015 $-57
2014 $-16
2013 $-5
BeOne Medicines - Quarterly Operating Income
(Millions of US $)
2025-03-31 $11
2024-12-31 $-79
2024-09-30 $-120
2024-06-30 $-107
2024-03-31 $-261
2023-12-31 $-384
2023-09-30 $-134
2023-06-30 $-319
2023-03-31 $-371
2022-12-31 $-469
2022-09-30 $-438
2022-06-30 $-439
2022-03-31 $-443
2021-12-31 $-572
2021-09-30 $-462
2021-06-30 $-475
2021-03-31 $70
2020-12-31 $-485
2020-09-30 $-440
2020-06-30 $-359
2020-03-31 $-374
2019-12-31 $-388
2019-09-30 $-312
2019-06-30 $-86
2019-03-31 $-174
2018-12-31 $-281
2018-09-30 $-151
2018-06-30 $-163
2018-03-31 $-111
2017-12-31 $-104
2017-09-30 $115
2017-06-30 $-58
2017-03-31 $-52
2016-12-31 $-37
2016-09-30 $-35
2016-06-30 $-25
2016-03-31 $-20
2015-12-31 $5
2015-09-30
2015-06-30 $-7
2015-03-31 $-10
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $27.635B $3.810B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.549B 28.72
Zoetis (ZTS) United States $69.297B 25.85
Takeda Pharmaceutical (TAK) Japan $47.856B 9.52
Daiichi Sankyo, - (DSNKY) Japan $42.661B 21.86
Sandoz Group AG (SDZNY) Switzerland $24.908B 0.00
Summit Therapeutics (SMMT) United States $18.864B 0.00
Merck (MKKGY) Germany $16.659B 12.21
Shionogi (SGIOY) Japan $14.241B 14.27
United Therapeutics (UTHR) United States $13.427B 11.88
Neurocrine Biosciences (NBIX) United States $13.373B 45.81
Orion OYJ (ORINY) Finland $11.038B 29.85
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.768B 47.50
Corcept Therapeutics (CORT) United States $7.717B 62.73
Madrigal Pharmaceuticals (MDGL) United States $7.102B 0.00
Ionis Pharmaceuticals (IONS) United States $6.772B 0.00
Grifols, S.A (GRFS) Spain $6.683B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.265B 16.01
Soleno Therapeutics (SLNO) United States $4.171B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $3.025B 19.90
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.639B 14.27
Catalyst Pharmaceuticals (CPRX) United States $2.637B 9.24
NewAmsterdam Pharma (NAMS) Netherlands $2.489B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.021B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
Ocular Therapeutix (OCUL) United States $1.795B 0.00
ARS Pharmaceuticals (SPRY) United States $1.758B 0.00
Endo (NDOI) United States $1.588B 0.00
Evotec AG (EVO) Germany $1.463B 0.00
Harrow (HROW) United States $1.307B 0.00
Guardian Pharmacy Services (GRDN) United States $1.290B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.221B 24.43
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Ardelyx (ARDX) United States $1.103B 0.00
ProKidney (PROK) United States $1.080B 0.00
Collegium Pharmaceutical (COLL) United States $1.055B 5.69
Akebia Therapeutics (AKBA) United States $1.043B 0.00
Dyne Therapeutics (DYN) United States $1.013B 0.00
Verve Therapeutics (VERV) United States $0.983B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.971B 0.00
Xeris Biopharma Holdings (XERS) United States $0.851B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
KalVista Pharmaceuticals (KALV) United States $0.760B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.750B 0.00
Zevra Therapeutics (ZVRA) United States $0.699B 0.00
Xencor (XNCR) United States $0.630B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
USANA Health Sciences (USNA) United States $0.607B 13.19
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
Theravance Biopharma (TBPH) United States $0.574B 0.00
Organogenesis (ORGO) United States $0.570B 0.00
Bioventus (BVS) United States $0.559B 14.19
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Siga Technologies (SIGA) United States $0.490B 10.24
Tourmaline Bio (TRML) United States $0.487B 0.00
Savara (SVRA) United States $0.434B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Altimmune (ALT) United States $0.346B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.315B 0.00
AleAnna (ANNA) United States $0.314B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
Aldeyra Therapeutics (ALDX) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 26.76
OmniAb (OABI) United States $0.250B 0.00
Nanobiotix S.A (NBTX) France $0.243B 0.00
Esperion Therapeutics (ESPR) United States $0.234B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.221B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Journey Medical (DERM) United States $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Liminatus Pharma (LIMN) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.144B 0.00
Lyell Immunopharma (LYEL) United States $0.143B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Korro Bio (KRRO) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.110B 18.11
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
VAXART, INC (VXRT) United States $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Jupiter Neurosciences (JUNS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Metagenomi (MGX) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.078B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Vivos Therapeutics (VVOS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
BioVie (BIVI) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.13
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00